Journal Article

Candidacidal activity of a monoclonal antibody that binds with glycosyl moieties of proteins of Candida albicans

Amol Kavishwar and P. K Shukla

in Medical Mycology

Published on behalf of International Society for Human and Animal Mycology

Volume 44, issue 2, pages 159-167
Published in print March 2006 | ISSN: 1369-3786
Published online March 2006 | e-ISSN: 1460-2709 | DOI: https://dx.doi.org/10.1080/13693780500266038
Candidacidal activity of a monoclonal antibody that binds with glycosyl moieties of proteins of Candida albicans

More Like This

Show all results sharing these subjects:

  • Mycology and Fungi
  • Infectious Diseases
  • Medical Toxicology
  • Veterinary Medicine
  • Environmental Science

GO

Show Summary Details

Preview

The incidence of life threatening mycoses caused by opportunistic fungi has increased dramatically in recent years with Candida and Aspergillus being the most commonly encountered species. Candida albicans ranks among the four most common causes of bloodstream infections and is responsible for vulvovaginal candidiasis in the majority of women in their reproductive years. Limited spectrum of antifungal activity of currently available antifungals and emergence of resistance has become a serious problem. Therefore, in search of an alternative form of treatment of candidiasis, in the present study a monoclonal antibody (MAb-G5) of IgA isotype was identified from the hybridoma produced by the fusion of lymphocytes of C. albicans immunized mouse with Sp2/O cells. The MAb-G5 exhibited in vitro candidacidal activity and was also found to be useful for treatment and prophylactic use under experimental conditions in vivo.

Keywords: Candida albicans; Monoclonal IgA; candidacidal; vaginal candidiasis; flow cytometry

Journal Article.  5313 words.  Illustrated.

Subjects: Mycology and Fungi ; Infectious Diseases ; Medical Toxicology ; Veterinary Medicine ; Environmental Science

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.